SARS-CoV-2 is not unique in its ability to cause post-acute sequelae; certain acute
infections have long been associated with an unexplained chronic disability in a minority of …

Background After almost 2 years of fighting against SARS-CoV-2 pandemic, the number of
patients enduring persistent symptoms long after acute infection is a matter of concern. This …

Background Post-acute coronavirus 2019 (COVID-19) syndrome is now recognized as a
complex systemic disease that is associated with substantial morbidity. Objectives To …

Accumulating evidence points toward a very high prevalence of prolonged neurological
symptoms among coronavirus disease 2019 (COVID-19) survivors. To date, there are no …

Background As the coronavirus disease 2019 (COVID-19) pandemic continues to progress,
awareness about its long-term impacts has been growing. To date, studies on the long-term …

Recent data suggest a suboptimal antibody response to COVID-19 vaccination in patients
with hematological malignancies. Neutralizing antibodies (NAbs) against SARS-CoV-2 were …

Background After recovering from coronavirus disease 2019 (COVID-19), a considerable
number of patients report long-term sequelae. The epidemiologic data vary widely in the …

There have been hundreds of millions of cases of coronavirus disease 2019 (COVID-19),
which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With …

Coronavirus disease 2019 (COVID-19) has caused tremendous morbidity and mortality
worldwide. The large number of post-COVID survivors has drawn attention to the …

In the post-pandemic COVID-19 period, human activities have returned to normal and
COVID-19 cases are usually mild. However, patients with multiple myeloma (MM) present an …